Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD

NCT06707753 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Wet Age-related Macular Degeneration (wAMD)

Interventions

DRUG: AL-001

Sponsor

Beijing Anlong Biopharmaceutical Co., Ltd.